Per Kogner

Publications
Public outreach and news

Articles

Article: CANCER LETTERS. 2024;605:217261
The ROCK-1/2 inhibitor RKI-1447 blocks N-MYC, promotes cell death, and emerges as a synergistic partner for BET inhibitors in neuroblastoma
Pepich A; Tummler C; Abu Ajamieh S; Treis D; Boje AS; Vellema Q; Tsea I; Akerlund E; Seashore-Ludlow B; Fard SS; Kogner P; Johnsen JI; Wickstrom M
Article: CANCER RESEARCH COMMUNICATIONS. 2024;4(9):2553-2564
Long-Lasting Response to Lorlatinib in Patients with ALK-Driven Relapsed or Refractory Neuroblastoma Monitored with Circulating Tumor DNA Analysis
Ek T; Ibrahim RR; Vogt H; Georgantzi K; Trager C; Gaarder J; Djos A; Rahmqvist I; Mellstroem E; Pujol-Calderon F; Vannas C; Hansson L; Fagman H; Treis D; Fransson S; Osterlund T; Chuang T-P; Verhoeven BM; Stahlberg A; Palmer RH; Hallberg B; Martinsson T; Kogner P; Dalin M
Article: JOURNAL OF TRANSLATIONAL MEDICINE. 2024;22(1):808
Altered methylation of imprinted genes in neuroblastoma: implications for prognostic refinement
Suman M; Lofgren M; Fransson S; Yousuf JI; Svensson J; Djos A; Martinsson T; Kogner P; Kling T; Caren H
Article: MOLECULAR CANCER. 2024;23(1):180
Joint single-cell genetic and transcriptomic analysis reveal pre-malignant SCP-like subclones in human neuroblastoma
Olsen TK; Otte J; Mei S; Embaie BT; Kameneva P; Cheng H; Gao T; Zachariadis V; Tsea I; Bjorklund A; Kryukov E; Hou Z; Johansson A; Sundstrom E; Martinsson T; Fransson S; Stenman J; Fard SS; Johnsen JI; Kogner P; Adameyko I; Enge M; Kharchenko PV; Baryawno N
Article: AMERICAN JOURNAL OF MEDICAL GENETICS, PART A. 2024;194(12):e63812
Occurrence of cancer in Marfan syndrome: Report of two patients with neuroblastoma and review of the literature
Maya-Gonzalez C; Delgado-Vega AM; Taylan F; Robinson KL; Hansson L; Pal N; Fagman H; Puls F; Wessman S; Stenman J; Georgantzi K; Fransson S; De Stahl TD; Ek T; Palmer R; Tesi B; Kogner P; Martinsson T; Nordgren A
Article: GENES CHROMOSOMES AND CANCER. 2024;63(7):e23260
Loss of Chromosome Y in Neuroblastoma Is Associated With High-Risk Disease, 11q-Deletion, and Telomere Maintenance
Djos A; Svensson J; Gaarder J; Umapathy G; Nilsson S; Ek T; Vogt H; Georgantzi K; Ora I; Trager C; Kogner P; Martinsson T; Fransson S
Article: THE LANCET REGIONAL HEALTH. EUROPE. 2024;39:100881
Diagnostic yield and clinical impact of germline sequencing in children with CNS and extracranial solid tumors - a nationwide, prospective Swedish study
Tesi B; Robinson KL; Abel F; Stahl TDD; Orrsjoe S; Poluha A; Hellberg M; Wessman S; Samuelsson S; Frisk T; Vogt H; Henning K; Sabel M; Ek T; Pal N; Nyman P; Giraud G; Wille J; Pronk CJ; Noren-Nystroem U; Borssen M; Fili M; Stalhammar G; Herold N; Tettamanti G; Maya-Gonzalez C; Arvidsson L; Rosen A; Ekholm K; Kuchinskaya E; Hallbeck A-L; Nordling M; Palmebaeck P; Kogner P; Smoler GK; Laehteenmaeki P; Fransso S; Martinsson T; Shamik A; Mertens F; Rosenquist R; Wirta V; Tham E; Grillner P; Sandgren J; Ljungman G; Gisselsson D; Taylan F; Nordgren A
Article: NUCLEIC ACIDS RESEARCH (NAR). 2024;52(5):2648-2671
METTL3 drives telomere targeting of TERRA lncRNA through m⁶A-dependent R-loop formation: a therapeutic target for ALT-positive neuroblastoma
Vaid R; Thombare K; Mendez A; Burgos-Panadero R; Djos A; Jachimowicz D; Lundberg KI; Bartenhagen C; Kumar N; Tummler C; Sihlbom C; Fransson S; Johnsen JI; Kogner P; Martinsson T; Fischer M; Mondal T
Article: CANCERS. 2024;16(4):812
Recent Advances in Neuroblastoma Research
Johnsen JI; Kogner P
Article: JCI INSIGHT. 2024;9(6):e173337
Single-cell analyses of metastatic bone marrow in human neuroblastoma reveals microenvironmental remodeling and metastatic
Mei S; Alchahin AM; Embaie BT; Gavriliuc IM; Verhoeven BM; Zhao T; Li X; Jeffries NE; Pepich A; Sarkar H; Olsen TK; Wickstrom M; Stenman J; Reina-Bedoya O; Kharchenko PV; Saylor PJ; Johnsen JI; Sykes DB; Kogner P; Baryawno N
Article: MOLECULAR ONCOLOGY. 2024;18(2):317-335
High-content screening of drug combinations of an mPGES-1 inhibitor in multicellular tumor spheroids leads to mechanistic insights into neuroblastoma chemoresistance
Zaghmi A; Aybay E; Jiang L; Shang M; Steinmetz-Spah J; Wermeling F; Kogner P; Korotkova M; Ostling P; Jakobsson P-J; Seashore-Ludlow B; Larsson K
Article: JOURNAL OF THE ENDOCRINE SOCIETY. 2024;8(3):bvae009
Humanin Treatment Protects Against Venetoclax-Induced Bone Growth Retardation in Ex Vivo Cultured Rat Bones.
Velentza L; Wickström M; Kogner P; Ohlsson C; Zaman F; Sävendahl L
Article: FRONTIERS IN ONCOLOGY. 2024;14:1408729
Heterogeneous SSTR2 target expression and a novel KIAA1549::BRAF fusion clone in a progressive metastatic lesion following ¹⁷⁷Lutetium-DOTATATE molecular radiotherapy in neuroblastoma: a case report
Park SWS; Fransson S; Sundquist F; Nilsson JN; Gryback P; Wessman S; Stromgren J; Djos A; Fagman H; Sjoegren H; Georgantzi K; Herold N; Kogner P; Granberg D; Gaze MN; Martinsson T; Karlsson K; Stenman JJE
Article: CANCERS. 2023;15(24):5732
Telomere Maintenance Mechanisms in a Cohort of High-Risk Neuroblastoma Tumors and Its Relation to Genomic Variants in the TERT and ATRX Genes
Djos A; Thombare K; Vaid R; Gaarder J; Umapathy G; Reinsbach SE; Georgantzi K; Stenman J; Caren H; Ek T; Mondal T; Kogner P; Martinsson T; Fransson S
Article: JCO PRECISION ONCOLOGY. 2023;7:e2300039
Diagnostic Yield From a Nationwide Implementation of Precision Medicine for all Children With Cancer
Wadensten E; Wessman S; Abel F; De Stahl TD; Tesi B; Pietras CO; Arvidsson L; Taylan F; Fransson S; Vogt H; Poluha A; Pradhananga S; Hellberg M; Lagerstedt-Robinson K; Raj Somarajan P; Samuelsson S; Orrsjo S; Maqbool K; Henning K; Strid T; Ek T; Fagman H; Bontell TO; Martinsson T; Puls F; Kogner P; Wirta V; Pronk CJ; Wille J; Rosenquist R; Nister M; Mertens F; Sabel M; Noren-Nystrom U; Grillner P; Nordgren A; Ljungman G; Sandgren J; Gisselsson D
Article: JOURNAL OF TRANSLATIONAL MEDICINE. 2023;21(1):342
The Swedish childhood tumor biobank: systematic collection and molecular characterization of all pediatric CNS and other solid tumors in Sweden
de Stahl TD; Shamikh A; Mayrhofer M; Juhos S; Basmaci E; Prochazka G; Garcia M; Somarajan PR; Zielinska-Chomej K; Illies C; Ora I; Siesjo P; Sandstrom P-E; Stenman J; Sabel M; Gustavsson B; Kogner P; Pfeifer S; Ljungman G; Sandgren J; Nister M
Article: SCIENTIFIC REPORTS. 2023;13(1):8054
Pharmacological inhibition of BCL-2 with the FDA-approved drug venetoclax impairs longitudinal bone growth
Velentza L; Wickstrom M; Kogner P; Ohlsson C; Zaman F; Savendahl L
Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2023;62(2):27
Identification of recurrent 3q13.31 chromosomal rearrangement indicates LSAMP as a tumor suppressor gene in neuroblastoma
Martinez-Monleon A; Gaarder J; Djos A; Kogner P; Fransson S
Article: FRONTIERS IN PHARMACOLOGY. 2023;14:1183720
The multiple functions of miR-574-5p in the neuroblastoma tumor microenvironment
Proestler E; Donzelli J; Nevermann S; Breitwieser K; Koch LF; Best T; Fauth M; Wickstrom M; Harter PN; Kogner P; Lavieu G; Larsson K; Saul MJ
Article: DIAGNOSTICS. 2022;12(9):2260
Multifocal Neuroblastoma and Central Hypoventilation in An Infant with Germline ALK F1174I Mutation
Djos A; Treis D; Fransson S; Murkes LG; Wessman S; Asmundsson J; Markstrom A; Kogner P; Martinsson T
Article: JCI INSIGHT. 2022;7(17):e153836
DHODH is an independent prognostic marker and potent therapeutic target in neuroblastoma
Olsen TK; Dyberg C; Embaie BT; Alchahin A; Milosevic J; Ding J; Otte J; Tummler C; Myrberg IH; Westerhout EM; Koster J; Versteeg R; Ding H-F; Kogner P; Johnsen JI; Sykes DB; Baryawno N
Article: SCIENTIFIC REPORTS. 2022;12(1):12420
Amplification of CDK4 and MDM2: a detailed study of a high-risk neuroblastoma subgroup
Martinez-Monleon A; Oberg HK; Gaarder J; Berbegall AP; Javanmardi N; Djos A; Ussowicz M; Taschner-Mandl S; Ambros IM; Ora I; Sandstedt B; Beiske K; Ladenstein R; Noguera R; Ambros PF; Murkes LG; Ljungman G; Kogner P; Fransson S; Martinsson T
Article: CELL REPORTS MEDICINE. 2022;3(6):100657
The immune cell atlas of human neuroblastoma
Verhoeven BM; Mei S; Olsen TK; Gustafsson K; Valind A; Lindstrom A; Gisselsson D; Fard SS; Hagerling C; Kharchenko PV; Kogner P; Johnsen JI; Baryawno N
Article: LIFE SCIENCES. 2022;295:120394
Omega-3 fatty acids decrease CRYAB, production of oncogenic prostaglandin E₂ and suppress tumor growth in medulloblastoma
Ljungblad L; Bergqvist F; Tummler C; Madawala S; Olsen TK; Andonova T; Jakobsson P-J; Johnsen JI; Pickova J; Strandvik B; Kogner P; Gleissman H; Wickstrom M
Article: BMC GENOMICS. 2022;23(1):149
TC-hunter: identification of the insertion site of a transgenic gene within the host genome
Borjesson V; Martinez-Monleon A; Fransson S; Kogner P; Johnsen JI; Milosevic J; Lopez MD
Article: CANCERS. 2022;14(2):380
Whole-Body MRI Surveillance-Baseline Findings in the Swedish Multicentre Hereditary TP53-Related Cancer Syndrome Study (SWEP53)
Omran M; Tham E; Brandberg Y; Ahlstrom H; Lundgren C; Paulsson-Karlsson Y; Kuchinskaya E; Silander G; Rosen A; Persson F; Leonhardt H; Stenmark-Askmalm M; Berg J; van Westen D; Bajalica-Lagercrantz S; Blomqvist L
Article: JCO PRECISION ONCOLOGY. 2022;6:e2100271
Sustained Response to Entrectinib in an Infant With a Germline ALKAL2 Variant and Refractory Metastatic Neuroblastoma With Chromosomal 2p Gain and Anaplastic Lymphoma Kinase and Tropomyosin Receptor Kinase Activation
Treis D; Umapathy G; Fransson S; Guan J; Mendoza-Garcia P; Siaw JT; Wessman S; Murkes LG; Stenman JJE; Djos A; Elfman LHM; Johnsen JI; Hallberg B; Palmer RH; Martinsson T; Kogner P
Article: NEURO-ONCOLOGY ADVANCES. 2022;4(1):vdac028
Filamin A increases aggressiveness of human neuroblastoma
Bandaru S; Prajapati B; Juvvuna PK; Dosa S; Kogner P; Johnsen JI; Kanduri C; Akyurek LM
Article: FRONTIERS IN PEDIATRICS. 2022;10:836230
A Phase II Trial of a Personalized, Dose-Intense Administration Schedule of ¹⁷⁷Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-Risk Neuroblastoma-LuDO-N
Sundquist F; Georgantzi K; Jarvis KB; Brok J; Koskenvuo M; Rascon J; van Noesel M; Grybaeck P; Nilsson J; Braat A; Sundin M; Wessman S; Herold N; Hjorth L; Kogner P; Granberg D; Gaze M; Stenman J
Article: CANCERS. 2021;13(23):6042
PPM1D Is a Therapeutic Target in Childhood Neural Tumors
Milosevic J; Treis D; Fransson S; Gallo-Oller G; Sveinbjoernsson B; Eissler N; Tanino K; Sakaguchi K; Martinsson T; Wickstroem M; Kogner P; Johnsen JI
Article: CANCERS. 2021;13(21):5493
High Expression of PPM1D Induces Tumors Phenotypically Similar to TP53 Loss-of-Function Mutations in Mice
Milosevic J; Fransson S; Gulyas M; Olsen TK; Gallo-Oller G; Treis D; Elfman LHM; Wilhelm M; Martinsson T; Baryawno N; Kogner P; Johnsen JI
Article: JOURNAL OF CLINICAL ONCOLOGY. 2021;39(30):3377-3390
Frequency and Prognostic Impact of ALK Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1)
Bellini A; Poetschger U; Bernard V; Lapouble E; Baulande S; Ambros PF; Auger N; Beiske K; Bernkopf M; Betts DR; Bhalshankar J; Bown N; de Preter K; Clement N; Combaret V; de Mora JF; George SL; Jimenez I; Jeison M; Marques B; Martinsson T; Mazzocco K; Morini M; Muehlethaler-Mottet A; Noguera R; Pierron G; Rossing M; Taschner-Mandl S; Van Roy N; Vicha A; Chesler L; Balwierz W; Castel V; Elliott M; Kogner P; Laureys G; Luksch R; Malis J; Popovic-Beck M; Ash S; Delattre O; Valteau-Couanet D; Tweddle DA; Ladenstein R; Schleiermacher G
Article: NATURE COMMUNICATIONS. 2021;12(1):5309
Single-nuclei transcriptomes from human adrenal gland reveal distinct cellular identities of low and high-risk neuroblastoma tumors
Bedoya-Reina OC; Li W; Arceo M; Plescher M; Bullova P; Pui H; Kaucka M; Kharchenko P; Martinsson T; Holmberg J; Adameyko I; Deng Q; Larsson C; Juhlin CC; Kogner P; Schlisio S
Article: PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS. 2021;169:102285
Body surface area-based omega-3 fatty acids supplementation strongly correlates to blood concentrations in children.
Ljungblad L; Gleissman H; Hedberg G; Wickstrom M; Eissler N; Pickova J; Johnsen JI; Tedroff K; Strandvik B; Kogner P
Article: NATURE GENETICS. 2021;53(5):694-706
Single-cell transcriptomics of human embryos identifies multiple sympathoblast lineages with potential implications for neuroblastoma origin
Kameneva P; Artemov AV; Kastriti ME; Faure L; Olsen TK; Otte J; Erickson A; Semsch B; Andersson ER; Ratz M; Frisen J; Tischler AS; de Krijger RR; Bouderlique T; Akkuratova N; Vorontsova M; Gusev O; Fried K; Sundstrom E; Mei S; Kogner P; Baryawno N; Kharchenko PV; Adameyko I
Article: NUCLEIC ACIDS RESEARCH (NAR). 2021;49(5):2509-2521
Aberrant splicing in neuroblastoma generates RNA-fusion transcripts and provides vulnerability to spliceosome inhibitors
Shi Y; Yuan J; Rraklli V; Maxymovitz E; Cipullo M; Liu M; Li S; Westerlund I; Bedoya-Reina OC; Bullova P; Rorbach J; Juhlin CC; Stenman A; Larsson C; Kogner P; O'Sullivan MJ; Schlisio S; Holmberg J
Article: CANCER CELL INTERNATIONAL. 2021;21(1):170
The loss of DLG2 isoform 7/8, but not isoform 2, is critical in advanced staged neuroblastoma
Keane S; Martinsson T; Kogner P; Ejeskar K
Article: CANCER RESEARCH. 2021;81(6):1457-1471
Subcellular Distribution of p53 by the p53-Responsive lncRNA NBAT1 Determines Chemotherapeutic Response in Neuroblastoma
Mitra S; Muralidharan SV; Di Marco M; Juvvuna PK; Kosalai ST; Reischl S; Jachimowicz D; Subhash S; Raimondi I; Kurian L; Huarte M; Kogner P; Fischer M; Johnsen JI; Mondal T; Kanduri C
Article: EUROPEAN JOURNAL OF CANCER. 2021;144:1-8
Central nervous system relapse in high-risk stage 4 neuroblastoma: The HR-NBL1/SIOPEN trial experience
Berlanga P; Pasqualini C; Poetschger U; Sanguesa C; Castellani MR; Canete A; Luksch R; Elliot M; Schreier G; Kropf M; Morgenstern D; Papadakis V; Ash S; Ruud E; Brock P; Wieczorek A; Kogner P; Trahair T; Ambros P; Boterberg T; Castel V; Valteau-Couanet D; Ladenstein R
Article: SCIENTIFIC REPORTS. 2020;10(1):22432
Whole-genome sequencing of recurrent neuroblastoma reveals somatic mutations that affect key players in cancer progression and telomere maintenance
Fransson S; Martinez-Monleon A; Johansson M; Sjoberg R-M; Bjorklund C; Ljungman G; Torben E; Kogner P; Martinsson T
Article: JOURNAL OF CLINICAL ONCOLOGY. 2020;38(31):3685-3697
Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable MYCN-Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group
Ambros IM; Tonini G-P; Poetschger U; Gross N; Mosseri V; Beiske K; Berbegall AP; Benard J; Bown N; Caron H; Combaret V; Couturier J; Defferrari R; Delattre O; Jeison M; Kogner P; Lunec J; Marques B; Martinsson T; Mazzocco K; Noguera R; Schleiermacher G; Valent A; Van Roy N; Villamon E; Janousek D; Pribill I; Glogova E; Attiyeh EF; Hogarty MD; Monclair TF; Holmes K; Valteau-Couanet D; Castel V; Tweddle DA; Park JR; Cohn S; Ladenstein R; Beck-Popovic M; De Bernardi B; Michon J; Pearson ADJ; Ambros PF
Article: CELL REPORTS. 2020;32(12):108171
11q Deletion or ALK Activity Curbs DLG2 Expression to Maintain an Undifferentiated State in Neuroblastoma
Siaw JT; Javanmardi N; Van den Eynden J; Lind DE; Fransson S; Martinez-Monleon A; Djos A; Sjoberg R-M; Ostensson M; Caren H; Troen G; Beiske K; Berbegall AP; Noguera R; Lai W-Y; Kogner P; Palmer RH; Hallberg B; Martinsson T
Article: THE FASEB JOURNAL. 2020;34(8):11101-11114
Establishment of an in vitro 3D model for neuroblastoma enables preclinical investigation of combined tumor-stroma drug targeting
Kock A; Bergqvist F; Steinmetz J; Elfman LHM; Korotkova M; Johnsen JI; Jakobsson P-J; Kogner P; Larsson K
Article: NATURE COMMUNICATIONS. 2020;11(1):71
Integrative discovery of treatments for high-risk neuroblastoma
Almstedt E; Elgendy R; Hekmati N; Rosen E; Warn C; Olsen TK; Dyberg C; Doroszko M; Larsson I; Sundstrom A; Henriksson MA; Pahlman S; Bexell D; Vanlandewijck M; Kogner P; Jornsten R; Krona C; Nelander S
Article: HEREDITARY CANCER IN CLINICAL PRACTICE. 2020;18(1):1
Whole-body MRI within a surveillance program for carriers with clinically actionable germline TP53 variants-the Swedish constitutional TP53 study SWEP53
Omran M; Blomqvist L; Brandberg Y; Pal N; Kogner P; Stahlbom AK; Tham E; Bajalica-Lagercrantz S
Article: GENES CHROMOSOMES AND CANCER. 2020;59(1):50-57
Analysis of ALK, MYCN, and the ALK ligand ALKAL2 (FAM150B/AUGα) in neuroblastoma patient samples with chromosome arm 2p rearrangements
Javanmardi N; Fransson S; Djos A; Umapathy G; Ostensson M; Milosevic J; Borenaes M; Hallberg B; Kogner P; Martinsson T; Palmer RH
Article: CANCERS. 2019;12(1):E73-73
Inhibition of Rho-Associated Kinase Suppresses Medulloblastoma Growth
Dyberg C; Andonova T; Olsen TK; Brodin B; Kool M; Kogner P; Johnsen JI; Wickstrom M
Article: ONCOGENE. 2019;38(15):2800-2813
Inhibitors of ribosome biogenesis repress the growth of MYCN-amplified neuroblastoma
Hald OH; Olsen L; Gallo-Oller G; Elfman LHM; Lokke C; Kogner P; Sveinbjornsson B; Flaegstad T; Johnsen JI; Einvik C
Article: SCIENTIFIC REPORTS. 2019;9(1):2199
Low Frequency ALK Hotspots Mutations In Neuroblastoma Tumours Detected By Ultra-deep Sequencing: Implications For ALK Inhibitor Treatment
Javanmardi N; Fransson S; Djos A; Sjoberg R-M; Nilsson S; Truve K; Kogner P; Martinsson T
Article: CANCERS. 2019;11(2):E202-202
SYK Inhibition Potentiates the Effect of Chemotherapeutic Drugs on Neuroblastoma Cells In Vitro
Tummler C; Dumitriu G; Wickstrom M; Coopman P; Valkov A; Kogner P; Johnsen JI; Moens U; Sveinbjornsson B
Article: STEM CELL RESEARCH. 2019;34:101356
Generation of induced pluripotent stem cell lines from two Neuroblastoma patients carrying a germline ALK R1275Q mutation
Navarro AM; Day K; Kogner P; Wilhelm M; Falk A
Article: PEDIATRIC BLOOD AND CANCER. 2018;65(11):e27363
Risk stratification of high-risk metastatic neuroblastoma: A report from the HR-NBL-1/SIOPEN study
Morgenstern DA; Poetschger U; Moreno L; Papadakis V; Owens C; Ash S; Pasqualini C; Luksch R; Garaventa A; Canete A; Elliot M; Wieczorek A; Laureys G; Kogner P; Malis J; Ruud E; Beck-Popovic M; Schleiermacher G; Valteau-Couanet D; Ladenstein R
Article: COLD SPRING HARBOR MOLECULAR CASE STUDIES. 2018;4(4):a002550
Clinical response of the novel activating ALK-I1171T mutation in neuroblastoma o the ALK inhibitor ceritinib
Guan J; Fransson S; Siaw JT; Treis D; Van den Eynden J; Chand D; Umapathy G; Ruuth K; Svenberg P; Wessman S; Shamikh A; Jacobsson H; Gordon L; Stenman J; Svensson P-J; Hansson M; Larsson E; Martinsson T; Palmer RH; Kogner P; Hallberg B
Article: EBIOMEDICINE. 2018;32:84-92
Inhibition of Microsomal Prostaglandin E Synthase-1 in Cancer-Associated Fibroblasts Suppresses Neuroblastoma Tumor Growth
Kock A; Larsson K; Bergqvist F; Eissler N; Elfman LHM; Raouf J; Korotkova M; Johnsen JI; Jakobsson P-J; Kogner P
Article: CANCER CELL. 2018;33(3):417-434.e7
Sense-Antisense lncRNA Pair Encoded by Locus 6p22.3 Determines Neuroblastoma Susceptibility via the USP36-CHD7-SOX9 Regulatory Axis
Mondal T; Juvvuna PK; Kirkeby A; Mitra S; Kosalai ST; Traxler L; Hertwig F; Wernig-Zorc S; Miranda C; Deland L; Volland R; Bartenhagen C; Bartsch D; Bandaru S; Engesser A; Subhash S; Martinsson T; Caren H; Akyurek LM; Kurian L; Kanduri M; Huarte M; Kogner P; Fischer M; Kanduri C
Article: PEDIATRIC HEMATOLOGY AND ONCOLOGY. 2018;35(2):156-165
Chromogranin A and neuron-specific enolase in neuroblastoma: Correlation to stage and prognostic factors
Georgantzi K; Skoldenberg EG; Stridsberg M; Kogner P; Jakobson A; Janson ET; Christofferson RHB
Article: PLOS ONE. 2018;13(1):e0190970
Doxorubicin-provoked increase of mitotic activity and concomitant drain of G0-pool in therapy-resistant BE(2)-C neuroblastoma
Hultman I; Haeggblom L; Rognmo I; Edqvist JJ; Blomberg E; Ali R; Phillips L; Sandstedt B; Kogner P; Fard SS; Ahrlund-Richter L
Article: ONCOTARGET. 2017;8(56):95135-95151
Inhibition of chemerin/CMKLR1 axis in neuroblastoma cells reduces clonogenicity and cell viability in vitro and impairs tumor growth in vivo
Tummler C; Snapkov I; Wickstrom M; Moens U; Ljungblad L; Elfman LHM; Winberg J-O; Kogner P; Johnsen JI; Sveinbjornsson B
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2017;114(32):E6603-E6612
Rho-associated kinase is a therapeutic target in neuroblastoma
Dyberg C; Fransson S; Andonova T; Sveinbjornsson B; Lannerholm-Palm J; Olsen TK; Forsberg D; Herlenius E; Martinsson T; Brodin B; Kogner P; Johnsen JI; Wickstrom M
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2017;114(30):E6137-E6146
Combined epigenetic and differentiation-based treatment inhibits neuroblastoma tumor growth and links HIF2α to tumor suppression
Westerlund I; Shi Y; Toskas K; Fell SM; Li S; Surova O; Sodersten E; Kogner P; Nyman U; Schlisio S; Holmberg J
Article: ONCOTARGET. 2017;8(21):34111-34127
Lithium protects hippocampal progenitors, cognitive performance and hypothalamus-pituitary function after irradiation to the juvenile rat brain
Zhou K; Xie C; Wickstrom M; Dolga AM; Zhang Y; Li T; Xu Y; Culmsee C; Kogner P; Zhu C; Blomgren K
Article: GENES & DEVELOPMENT. 2017;31(10):1036-1053
Neuroblast differentiation during development and in neuroblastoma requires KIF1Bβ-mediated transport of TRKA
Fell SM; Li S; Wallis K; Kock A; Surova O; Rraklli V; Hoefig CS; Li W; Mittag J; Henriksson MA; Kenchappa RS; Holmberg J; Kogner P; Schlisio S
Article: THE LANCET ONCOLOGY. 2017;18(4):500-514
Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial
Ladenstein R; Poetschger U; Pearson ADJ; Brock P; Luksch R; Castel V; Yaniv I; Papadakis V; Laureys G; Malis J; Balwierz W; Ruud E; Kogner P; Schroeder H; de Lacerda AF; Beck-Popovic M; Bician P; Garami M; Trahair T; Canete A; Ambros PF; Holmes K; Gaze M; Schreier G; Garaventa A; Vassal G; Michon J; Valteau-Couanet D
Article: NATURE MEDICINE. 2017;23(2):256-263
Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignancies
Herold N; Rudd SG; Ljungblad L; Sanjiv K; Myrberg IH; Paulin CBJ; Heshmati Y; Hagenkort A; Kutzner J; Paget BDG; Calderon-Montano JM; Loseva O; Jemth A-S; Bulli L; Axelsson H; Tesi B; Valerie NCK; Hoglund A; Bladh J; Wiita E; Sundin M; Uhlin M; Rassidakis G; Heyman M; Tamm KP; Warpman-Berglund U; Walfridsson J; Lehmann S; Grander D; Lundback T; Kogner P; Henter J-I; Helleday T; Schaller T
Article: CLINICAL CANCER RESEARCH. 2016;22(15):3849-3859
Targeting Suppressive Myeloid Cells Potentiates Checkpoint Inhibitors to Control Spontaneous Neuroblastoma
Mao Y; Eissler N; Le Blanc K; Johnsen JI; Kogner P; Kiessling R
Article: CELL REPORTS. 2016;16(4):979-993
Regulation of Nuclear Hormone Receptors by MYCN-Driven miRNAs Impacts Neural Differentiation and Survival in Neuroblastoma Patients
Ribeiro D; Klarqvist MDR; Westermark UK; Oliynyk G; Dzieran J; Kock A; Banares CS; Hertwig F; Johnsen JI; Fischer M; Kogner P; Loven J; Henriksson MA
Article: BMC CANCER. 2016;16:490
The role of formyl peptide receptor 1 (FPR1) in neuroblastoma tumorigenesis
Snapkov I; Oqvist CO; Figenschau Y; Kogner P; Johnsen JI; Sveinbjornsson B
Article: BMC CANCER. 2016;16:259
Planar cell polarity gene expression correlates with tumor cell viability and prognostic outcome in neuroblastoma
Dyberg C; Papachristou P; Haug BH; Lagercrantz H; Kogner P; Ringstedt T; Wickstrom M; Johnsen JI
Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2016;48(3):1103-1116
Estimation of copy number aberrations: Comparison of exome sequencing data with SNP microarrays identifies homozygous deletions of 19q13.2 and iin neuroblastoma
Fransson S; Ostensson M; Djos A; Javanmardi N; Kogner P; Martinsson T
Article: DEVELOPMENTAL CELL. 2016;36(2):164-178
The 1p36 Tumor Suppressor KIF 1Bβ Is Required for Calcineurin Activation, Controlling Mitochondrial Fission and Apoptosis
Li S; Fell SM; Surova O; Smedler E; Wallis K; Chen ZX; Hellman U; Johnsen JI; Martinsson T; Kenchappa RS; Uhlen P; Kogner P; Schlisio S
Article: EPIGENETICS. 2016;11(1):74-84
Genome-wide methylation profiling identifies novel methylated genes in neuroblastoma tumors
Olsson M; Beck S; Kogner P; Martinsson T; Caren H
Article: ONCOIMMUNOLOGY. 2016;5(12):e1232222
Regulation of myeloid cells by activated T cells determines the efficacy of PD-1 blockade
Eissler N; Mao Y; Brodin D; Reutersward P; Svahn HA; Johnsen JI; Kiessling R; Kogner P
Article: NATURE COMMUNICATIONS. 2015;6:8904
Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance
Wickstrom M; Dyberg C; Milosevic J; Einvik C; Calero R; Sveinbjornsson B; Sanden E; Darabi A; Siesjo P; Kool M; Kogner P; Baryawno N; Johnsen JI
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2015;112(26):8070-8075
COX/mPGES-1/PGE₂ pathway depicts an inflammatory-dependent high-risk neuroblastoma subset
Larsson K; Kock A; Idborg H; Henriksson MA; Martinsson T; Johnsen JI; Korotkova M; Kogner P; Jakobsson P-J
Article: GENES CHROMOSOMES AND CANCER. 2015;54(2):99-109
Intragenic Anaplastic Lymphoma Kinase (ALK) Rearrangements: Translocations as a Novel Mechanism of ALK Activation in Neuroblastoma Tumors
Fransson S; Hansson M; Ruuth K; Djos A; Berbegall A; Javanmardi N; Abrahamsson J; Palmer RH; Noguera R; Hallberg B; Kogner P; Martinsson T
Article: CANCER CELL. 2014;26(5):722-737
The Risk-Associated Long Noncoding RNA NBAT-1 Controls Neuroblastoma Progression by Regulating Cell Proliferation and Neuronal Differentiation
Pandey GK; Mitra S; Subhash S; Hertwig F; Kanduri M; Mishra K; Fransson S; Ganeshram A; Mondal T; Bandaru S; Ostensson M; Akyurek LM; Abrahamsson J; Pfeifer S; Larsson E; Shi L; Peng Z; Fischer M; Martinsson T; Hedborg F; Kogner P; Kanduri C
Article: JOURNAL OF CLINICAL ONCOLOGY. 2014;32(25):2727-2734
Emergence of New ALK Mutations at Relapse of Neuroblastoma
Schleiermacher G; Javanmardi N; Bernard V; Leroy Q; Cappo J; Frio TR; Pierron G; Lapouble E; Combaret V; Speleman F; de Wilde B; Djos A; Ora I; Hedborg F; Traeger C; Holmqvist B-M; Abrahamsson J; Peuchmaur M; Michon J; Janoueix-Lerosey I; Kogner P; Delattre O; Martinsson T
Article: INTERNATIONAL JOURNAL OF CANCER. 2014;134(7):1630-1637
Tropism of the in situ growth from biopsies of childhood neuroectodermal tumors following transplantation into experimental teratoma
Jamil S; Hultman I; Cedervall J; Ali RQ; Fuchs G; Gustavsson B; Asmundsson J; Sandstedt B; Kogner P; Ahrlund-Richter L
Article: CANCER DISCOVERY. 2014;4(4):434-451
RNA Helicase A Is a Downstream Mediator of KIF1Bβ Tumor-Suppressor Function in Neuroblastoma
Chen ZX; Wallis K; Fell SM; Sobrado VR; Hemmer MC; Ramskold D; Hellman U; Sandberg R; Kenchappa RS; Martinson T; Johnsen JI; Kogner P; Schlisio S
Article: JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2014;106(3):djt459
Protective Role of Humanin on Bortezomib-Induced Bone Growth Impairment in Anticancer Treatment
Eriksson E; Wickstrom M; Perup LS; Johnsen JI; Eksborg S; Kogner P; Savendahl L
Article: INTERNATIONAL JOURNAL OF CANCER. 2013;133(10):2351-2361
Frequent detection of human cytomegalovirus in neuroblastoma: A novel therapeutic target?
Wolmer-Solberg N; Baryawno N; Rahbar A; Fuchs D; Odeberg J; Taher C; Wilhelmi V; Milosevic J; Mohammad A-A; Martinsson T; Sveinbjornsson B; Johnsen JI; Kogner P; Soederberg-Naucler C
Article: BMC MEDICAL GENETICS. 2013;14:102
Aneuploidy in neuroblastoma tumors is not associated with inactivating point mutations in the STAG2 gene
Djos A; Fransson S; Kogner P; Martinsson T
Article: CLINICAL CANCER RESEARCH. 2013;19(18):5092-5103
Dual Targeting of Wild-Type and Mutant p53 by Small Molecule RITA Results in the Inhibition of N-Myc and Key Survival Oncogenes and Kills Neuroblastoma Cells In Vivo and In Vitro
Burmakin M; Shi Y; Hedstrom E; Kogner P; Selivanova G
Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2013;43(3):831-838
Neuroblastoma cells injected into experimental mature teratoma reveal a tropism for embryonic loose mesenchyme
Jamil S; Cedervall J; Hultman I; Ali R; Margaryan NV; Rasmuson A; Johnsen JI; Sveinbjornsson B; Dalianis T; Kanter L; Orrego A; Strizzi L; Hendrix MJC; Sandstedt B; Kogner P; Ahrlund-Richter L
Article: MOLECULAR CANCER. 2013;12(1):70
ERBB3 is a marker of a ganglioneuroblastoma/ganglioneuroma-like expression profile in neuroblastic tumours
Wilzen A; Krona C; Sveinbjornsson B; Kristiansson E; Dalevi D; Ora I; De Preter K; Stallings RL; Maris J; Versteeg R; Nilsson S; Kogner P; Abel F
Article: ONCOIMMUNOLOGY. 2013;2(7):e24658
Neuroblastoma-related inflammation May small doses of aspirin be suitable for small cancer patients?
Carlson L-M; Kogner P
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2013;110(25):10258-10263
MYC inhibition induces metabolic changes leading to accumulation of lipid droplets in tumor cells
Zirath H; Frenzel A; Oliynyk G; Segerstrom L; Westermark UK; Larsson K; Persson MM; Hultenby K; Lehtio J; Einvik C; Pahlman S; Kogner P; Jakobsson P-J; Henriksson MA
Article: BMC CANCER. 2013;13:231
Age dependence of tumor genetics in unfavorable neuroblastoma: arrayCGH profiles of 34 consecutive cases, using a Swedish 25-year neuroblastoma cohort for validation
Cetinkaya C; Martinsson T; Sandgren J; Trager C; Kogner P; Dumanski J; de Stahl TD; Hedborg F
Article: CARCINOGENESIS. 2013;34(5):1081-1088
Low-dose aspirin delays an inflammatory tumor progression in vivo in a transgenic mouse model of neuroblastoma
Carlson L-M; Rasmuson A; Idborg H; Segerstrom L; Jakobsson P-J; Sveinbjornsson B; Kogner P
Article: JOURNAL OF MOLECULAR SIGNALING. 2013;8(1):4
Aggressive neuroblastomas have high p110alpha but low p110delta and p55alpha/p50alpha protein levels compared to low stage neuroblastomas.
Fransson S; Kogner P; Martinsson T; Ejeskär K
Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2013;42(4):1239-1248
Expression of TWEAK/Fn14 in neuroblastoma: Implications in tumorigenesis
Pettersen I; Baryawno N; Abel F; Bakkelund WH; Zykova SN; Winberg J-O; Moens U; Rasmuson A; Kogner P; Johnsen JI; Sveinbjornsson B
Article: INTERNATIONAL JOURNAL OF CANCER. 2013;132(7):1516-1524
Targeting the hedgehog signal transduction pathway at the level of GLI inhibits neuroblastoma cell growth in vitro and in vivo
Wickstrom M; Dyberg C; Shimokawa T; Milosevic J; Baryawno N; Fuskevag OM; Larsson R; Kogner P; Zaphiropoulos PG; Johnsen JI
Article: ONCOIMMUNOLOGY. 2013;2(3):e23618
The microenvironment of human neuroblastoma supports the activation of tumor-associated T lymphocytes
Carlson L-M; De Geer A; Sveinbjornsson B; Orrego A; Martinsson T; Kogner P; Levitskaya J
Article: DISEASE MODELS & MECHANISMS. 2013;6(2):373-382
Cell culture and Drosophila model systems define three classes of anaplastic lymphoma kinase mutations in neuroblastoma
Chand D; Yamazaki Y; Ruuth K; Schonherr C; Martinsson T; Kogner P; Attiyeh EF; Maris J; Morozova O; Marra MA; Ohira M; Nakagawara A; Sandstrom P-E; Palmer RH; Hallberg B
Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2013;42(2):609-616
Stage-dependent expression of PI3K/Akt-pathway genes in neuroblastoma
Fransson S; Abel F; Kogner P; Martinsson T; Ejeskar K
Article: BMC MEDICAL GENETICS. 2012;13:83
Quantitative global and gene-specific promoter methylation in relation to biological properties of neuroblastomas
Kiss NB; Kogner P; Johnsen JI; Martinsson T; Larsson C; Geli J
Article: INTERNATIONAL JOURNAL OF CANCER. 2012;131(4):E555-E561
Hepatoblastoma in the Nordic countries
Licht SDF; Schmidt LS; Rod NH; Schmiegelow K; Lahteenmaki PM; Kogner P; Trager C; Stokland T; Schuz J
Article: MOLECULAR CANCER. 2012;11:40
The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma
Djos A; Martinsson T; Kogner P; Caren H
Article: BRITISH JOURNAL OF CANCER. 2012;106(11):1807-1815
Quiescence and γH2AX in neuroblastoma are regulated by ouabain/Na,K-ATPase
Hiyoshi H; Abdelhady S; Segerstrom L; Sveinbjornsson B; Nuriya M; Lundgren TK; Desfrere L; Miyakawa A; Yasui M; Kogner P; Johnsen JI; Andang M; Uhlen P
Article: CELL DEATH AND DISEASE. 2012;3(4):e298
Wig-1, a novel regulator of N-Myc mRNA and N-Myc-driven tumor growth
Vilborg A; Bersani C; Wickstrom M; Segerstrom L; Kogner P; Wiman KG
Article: PLOS ONE. 2012;7(1):e29331
Autocrine Prostaglandin E₂ Signaling Promotes Tumor Cell Survival and Proliferation in Childhood Neuroblastoma
Rasmuson A; Kock A; Fuskevag OM; Kruspig B; Simon-Santamaria J; Gogvadze V; Johnsen JI; Kogner P; Sveinbjornsson B
Article: PLOS ONE. 2012;7(12):e51297
Tumor Development, Growth Characteristics and Spectrum of Genetic Aberrations in the TH-MYCN Mouse Model of Neuroblastoma
Rasmuson A; Segerstrom L; Nethander M; Finnman J; Elfman LHM; Javanmardi N; Nilsson S; Johnsen JI; Martinsson T; Kogner P
Article: INTERNATIONAL JOURNAL OF CANCER. 2011;129(12):2958-2965
Effects of small molecule inhibitors of PI3K/Akt/mTOR signaling on neuroblastoma growth in vitro and in vivo
Segerstrom L; Baryawno N; Sveinbjornsson B; Wickstrom M; Elfman L; Kogner P; Johnsen JI
Article: CANCER LETTERS. 2011;310(2):222-231
Inhibition of the sonic hedgehog pathway by cyplopamine reduces the CD133+/CD15+cell compartment and the in vitro tumorigenic capability of neuroblastoma cells
Schiapparelli P; Shahi MH; Enguita-German M; Johnsen JI; Kogner P; Lazcoz P; Castresana JS
Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2011;39(5):1063-1071
MYCN amplicon junctions as tumor-specific targets for minimal residual disease detection in neuroblastoma
Kryh H; Abrahamsson J; Jegeras E; Sjoberg R-M; Devenney I; Kogner P; Martinsson T
Article: JOURNAL OF CLINICAL INVESTIGATION. 2011;121(10):4043-4055
Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic target
Baryawno N; Rahbar A; Wolmer-Solberg N; Taher C; Odeberg J; Darabi A; Khan Z; Sveinbjornsson B; Fuskevag O-M; Segerstrom L; Nordenskjold M; Siesjo P; Kogner P; Johnsen JI; Soderberg-Naucler C
Article: BMC GENOMICS. 2011;12:443
Comprehensive SNP array study of frequently used neuroblastoma cell lines; copy neutral loss of heterozygosity is common in the cell lines but uncommon in primary tumors
Kryh H; Caren H; Erichsen J; Sjoberg R-M; Abrahamsson J; Kogner P; Martinsson T
Article: CARCINOGENESIS. 2011;32(7):1005-1012
MYCN-regulated miRNA-92 inhibits secretion of the tumor suppressor DICKKOPF-3 (DKK3) in neuroblastoma
Haug BH; Henriksen JR; Buechner J; Geerts D; Tomte E; Kogner P; Martinsson T; Flgstad T; Sveinbjornsson B; Einvik C
Article: INTERNATIONAL JOURNAL OF CANCER. 2011;128(9):2166-2173
Birth characteristics and Wilms tumors in children in the Nordic countries: a register-based case-control study
Schuz J; Schmidt LS; Kogner P; Lahteenmaki PM; Pal N; Stokland T; Schmiegelow K
Article: CANCER CELL INTERNATIONAL. 2011;11:9
A 6-gene signature identifies four molecular subgroups of neuroblastoma
Abel F; Dalevi D; Nethander M; Jornsten R; De Preter K; Vermeulen J; Stallings R; Kogner P; Maris J; Nilsson S
Article: INTERNATIONAL JOURNAL OF CANCER. 2011;128(7):1703-1711
Omega-3 fatty acid supplementation delays the progression of neuroblastoma in vivo
Gleissman H; Segerstrom L; Hamberg M; Ponthan F; Lindskog M; Johnsen JI; Kogner P
Article: BMC CANCER. 2011;11:66
Identification of epigenetically regulated genes that predict patient outcome in neuroblastoma
Caren H; Djos A; Nethander M; Sjoberg R-M; Kogner P; Enstrom C; Nilsson S; Martinsson T
Article: CANCER RESEARCH. 2011;71(1):98-105
Appearance of the Novel Activating F1174S ALK Mutation in Neuroblastoma Correlates with Aggressive Tumor Progression and Unresponsiveness to Therapy
Martinsson T; Eriksson T; Abrahamsson J; Caren H; Hansson M; Kogner P; Kamaraj S; Schonherr C; Weinmar J; Ruuth K; Palmer RH; Hallberg B
Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2010;37(5):1323-1330
Suppression of RIZ in biologically unfavourable neuroblastomas
Geli J; Kiss N; Kogner P; Larsson C
Article: CLINICAL CANCER RESEARCH. 2010;16(17):4353-4362
Meta-analysis of Neuroblastomas Reveals a Skewed ALK Mutation Spectrum in Tumors with MYCN Amplification
De Brouwer S; De Preter K; Kumps C; Zabrocki P; Porcu M; Westerhout EM; Lakeman A; Vandesompele J; Hoebeeck J; Van Maerken T; De Paepe A; Laureys G; Schulte JH; Schramm A; Van den Broecke C; Vermeulen J; Van Roy N; Beiske K; Renard M; Noguera R; Delattre O; Janoueix-Lerosey I; Kogner P; Martinsson T; Nakagawara A; Ohira M; Caron H; Eggert A; Cools J; Versteeg R; Speleman F
Article: JOURNAL OF CLINICAL ONCOLOGY. 2010;28(21):3516-3524
Randomized Trial of Prophylactic Granulocyte Colony-Stimulating Factor During Rapid COJEC Induction in Pediatric Patients With High-Risk Neuroblastoma: The European HR-NBL1/SIOPEN Study
Ladenstein R; Valteau-Couanet D; Brock P; Yaniv I; Castel V; Laureys G; Malis J; Papadakis V; Lacerda A; Ruud E; Kogner P; Garami M; Balwierz W; Schroeder H; Beck-Popovic M; Schreier G; Machin D; Potschger U; Pearson A
Article: CELL CYCLE. 2010;9(13):2548-2554
Medulloblastoma A disease with disorganized developmental signaling cascades
Baryawno N; Sveinbjornsson B; Kogner P; Johnsen JI
Article: BRITISH JOURNAL OF CANCER. 2010;102(11):1670-1675
Infectious exposure in the first years of life and risk of central nervous system tumours in children: analysis of birth order, childcare attendance and seasonality of birth
Schmidt LS; Kamper-Jorgensen M; Schmiegelow K; Johansen C; Lahteenmaki P; Trager C; Stokland T; Grell K; Gustafson G; Kogner P; Sehested A; Schuz J
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2010;107(9):4323-4328
High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset
Caren H; Kryh H; Nethander M; Sjoberg R-M; Trager C; Nilsson S; Abrahamsson J; Kogner P; Martinsson T
Article: THE FASEB JOURNAL. 2010;24(3):906-915
Docosahexaenoic acid metabolome in neural tumors: identification of cytotoxic intermediates
Gleissman H; Yang R; Martinod K; Lindskog M; Serhan CN; Johnsen JI; Kogner P
Article: CANCER RESEARCH. 2010;70(1):266-276
Small-Molecule Inhibitors of Phosphatidylinositol 3-Kinase/Akt Signaling Inhibit Wnt/β-Catenin Pathway Cross-Talk and Suppress Medulloblastoma Growth
Baryawno N; Sveinbjornsson B; Eksborg S; Chen C-S; Kogner P; Johnsen JI
Article: PLOS ONE. 2009;4(12):e8239
DNA from KI, WU and Merkel Cell Polyomaviruses Is Not Detected in Childhood Central Nervous System Tumours or Neuroblastomas
Giraud G; Ramqvist T; Pastrana DV; Pavot V; Lindau C; Kogner P; Orrego A; Buck CB; Allander T; Holm S; Gustavsson B; Dalianis T
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2009;106(44):18757-18762
Microsomal prostaglandin E synthase 1 determines tumor growth in vivo of prostate and lung cancer cells
Hanaka H; Pawelzik S-C; Johnsen JI; Rakonjac M; Terawaki K; Rasmuson A; Sveinbjornsson B; Schumacher MC; Hamberg M; Samuelsson B; Jakobsson P-J; Kogner P; Radmark O
Article: BMC MEDICAL GENOMICS. 2009;2:53
Verification of genes differentially expressed in neuroblastoma tumours: a study of potential tumour suppressor genes
Thorell K; Bergman A; Caren H; Nilsson S; Kogner P; Martinsson T; Abel F
Article: ANTICANCER RESEARCH. 2009;29(8):3311-3319
The Angiogenic Growth Factors HGF and VEGF in Serum and Plasma from Neuroblastoma Patients
Skoldenberg EG; Larsson A; Jakobson A; Hedborg F; Kogner P; Christofferson RH; Azarbayjani F
Article: INTERNATIONAL JOURNAL OF CANCER. 2009;124(5):1227-1234
Metronomic scheduling of imatinib abrogates clonogenicity of neuroblastoma cells and enhances their susceptibility to selected chemotherapeutic drugs in vitro and in vivo
Paimberg E; Johnsen JI; Paulsson J; Gleissman H; Wickstrom M; Edgren M; Ostman A; Kogner P; Lindskog M
Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2009;34(3):697-705
The Phox2 pathway is differentially expressed in neuroblastoma tumors, but no mutations were found in the candidate tumor suppressor gene PHOX2A
Wilzen A; Nilsson S; Sjoberg R-M; Kogner P; Martinsson T; Abel F
Article: INTERNATIONAL JOURNAL OF CANCER. 2008;123(12):2849-2855
mRNAs of tyrosine hydroxylase and dopa decarboxylase but not of GD2 synthase are specific for neuroblastoma minimal disease and predicts outcome for children with high-risk disease when measured at diagnosis
Trager C; Vernby A; Kullman A; Ora I; Kogner P; Kagedal B
Article: BIOCHEMICAL JOURNAL. 2008;416(2):153-159
High incidence of DNA mutations and gene amplifications of the ALK gene in advanced sporadic neuroblastoma tumours
Caren H; Abel F; Kogner P; Martinsson T
Article: JOURNAL OF PEDIATRIC HEMATOLOGY/ONCOLOGY. 2008;30(11):807-814
The Influence of Pediatric Cancer Diagnosis and Illness Complication Factors on Parental Distress
Hoven E; Anclair M; Samuelsson U; Kogner P; Boman KK
Article: NEURO-ONCOLOGY. 2008;10(5):661-674
Tumor-growth-promoting cyclooxygenase-2 prostaglandin E₂ pathway provides medulloblastoma therapeutic targets
Baryawno N; Sveinbjornsson B; Eksborg S; Orrego A; Segerstrom L; Oqvist CO; Holm S; Gustavsson B; Kagedal B; Kogner P; Johnsen JI
Article: THE FASEB JOURNAL. 2008;22(10):3525-3536
Expression of enzymes and receptors of the leukotriene pathway in human neuroblastoma promotes tumor survival and provides a target for therapy
Sveinbjornsson B; Rasmuson A; Baryawno N; Wan M; Pettersen I; Ponthan F; Orrego A; Haeggstrom JZ; Johnsen JI; Kogner P
Article: BMC GENOMICS. 2008;9:353
High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors:: Four cases of homozygous deletions of the CDKN2A gene
Caren H; Erichsen J; Olsson L; Enerback C; Sjoberg R-M; Abrahamsson J; Kogner P; Martinsson T
Article: INTERNATIONAL JOURNAL OF CANCER. 2008;123(2):389-394
Assessment of NORE1A as a putative tumor suppressor in human neuroblastoma
Geli J; Kogner P; Lanner F; Natalishvili N; Juhlin C; Kiss N; Clark GJ; Ekstrom TJ; Farnebo F; Larsson C
Article: ONCOGENE. 2008;27(20):2910-2922
Inhibitors of mammalian target of rapamycin downregulate MYCN protein expression and inhibit neuroblastoma growth in vitro and in vivo
Johnsen JI; Segerstrom L; Orrego A; Elfman L; Henriksson M; Kagedal B; Eksborg S; Sveinbjornsson B; Kogner P
Article: CANCER IMMUNOLOGY, IMMUNOTHERAPY. 2008;57(5):731-743
Soluble factors released by activated cytotoxic T lymphocytes interfere with death receptor pathways in neuroblastoma
De Geer A; Carlson L-M; Kogner P; Levitskaya J
Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2008;32(3):575-583
Analysis of neuroblastoma tumour progression;: loss of PHOX2B on 4p13 and 17q gain are early events in neuroblastoma tumourigenesis
Krona C; Caren H; Sjoberg R-M; Sandstedt B; Laureys G; Kogner P; Martinsson T
Article: CELL RESEARCH. 2008;18(3):398-411
Differentiation induced by physiological and pharmacological stimuli leads to increased antigenicity of human neuroblastoma cells
Carlson L-M; Pahlman S; De Geer A; Kogner P; Levitskaya J
Article: BRITISH JOURNAL OF CANCER. 2007;97(10):1416-1424
Genetic and epigenetic changes in the common Ip36 deletion in neuroblastoma tumours
Caren H; Fransson S; Ejeskar K; Kogner P; Martinsson T
Article: MOLECULAR CANCER THERAPEUTICS. 2007;6(9):2409-2417
The novel melphalan prodrug J1 inhibits neuroblastoma growth in vitro and in vivo
Wickstrom M; Johnsen JI; Ponthan F; Segerstrom L; Sveinbjornsson B; Lindskog M; Lovborg H; Viktorsson K; Lewensohn R; Kogner P; Larsson R; Gullbo J
Article: ENDOCRINE-RELATED CANCER. 2007;14(1):125-134
The Ras effectors NORE1A and RASSF1A are frequently inactivated in pheochromocytoma and abdominal paraganglioma
Geli J; Kiss N; Lanner F; Foukakis T; Natalishvili N; Larsson O; Kogner P; Hoog A; Clark GJ; Ekstrom TJ; Backdahl M; Farnebo F; Larsson C
Article: CLINICAL CANCER RESEARCH. 2007;13(3):1036-1044
Celecoxib prevents neuroblastoma tumor development and potentiates the effect of chemotherapeutic drugs in vitro and in vivo
Ponthan F; Wickstroem M; Gleissman H; Fuskevag OM; Segerstroem L; Sveinbjoernsson B; Redfern CPF; Eksborg S; Kogner P; Johnsen JI
Article: CLINICAL NUCLEAR MEDICINE. 2007;32(1):24-28
Different concentrations of I-123 MIBG and In-111 pentetreotide in the two main liver lobes in children -: Persisting regional functional differences after birth?
Jacobsson H; Hellstroem PM; Kogner P; Larsson SA
Article: INTERNATIONAL JOURNAL OF CANCER. 2006;119(3):493-500
The antimicrobial peptide, Lactoferricin B, is cytotoxic to neuroblastoma cells in vitro and inhibits xenograft growth in vivo
Eliassen LT; Berge G; Leknessund A; Wikman M; Lindin I; Lokke C; Ponthan F; Johnsen JI; Sveinbjornsson B; Kogner P; Flægstad T; Rekdal O
Article: INTERNATIONAL JOURNAL OF CANCER. 2006;118(10):2584-2593
Neuroblastoma cell death in response to docosahexaenoic acid: Sensitization to chemotherapy and arsenic-induced oxidative stress
Lindskog M; Gleissman H; Ponthan F; Castro J; Kogner P; Johnsen JI
Article: JOURNAL OF MOLECULAR NEUROSCIENCE. 2006;29(2):145-152
Gangliocytes in neuroblastic tumors express alarin, a novel peptide derived by differential splicing of the galanin-like peptide gene
Santic R; Fenninger K; Graf K; Schneider R; Hauser-Kronberger C; Schilling FH; Kogner P; Ratschek M; Jones N; Sperl W; Kofler B
Article: EUROPEAN JOURNAL OF CANCER. 2005;41(4):635-646
Imbalance of the mitochondrial pro- and anti-apoptotic mediators in neuroblastoma tumours with unfavourable biology
Abel F; Sjöberg RM; Nilsson S; Kogner P; Martinsson T
Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2004;25(6):1849-1857
Synergistic induction of apoptosis in neuroblastoma cells using a combination of cytostatic drugs with interferon-γ and TRAIL
Johnsen JI; Pettersen I; Ponthan F; Sveinbjornsson B; Flægstad T; Kogner P
Article: BRITISH JOURNAL OF CANCER. 2004;91(10):1835-1841
Investigation of the role of SDHB inactivation in sporadic phaeochromocytoma and neuroblastoma
Astuti D; Morris M; Krona C; Abel F; Gentle D; Martinsson T; Kogner P; Neumann HPH; Voutilainen R; Eng C; Rustin P; Latif F; Maher ER
Article: CANCER RESEARCH. 2004;64(20):7210-7215
Cyclooxygenase-2 is expressed in neuroblastoma, and nonsteroidal anti-inflammatory drugs induce apoptosis and inhibit tumor growth in vivo
Johnsen JI; Lindskog M; Ponthan F; Pettersen I; Elfman L; Orrego A; Sveinbjörnsson B; Kogner P
Article: JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2004;96(19):1457-1466
Predicting resistance or response to chemotherapy by proton magnetic resonance spectroscopy in neuroblastoma
Lindskog M; Spenger C; Jarvet J; Gräslund A; Kogner P
Article: JOURNAL OF PEDIATRICS. 2004;145(3):373-379
Serious illness in childhood: The different threats of cancer and diabetes from a parent perspective
Boman KK; Viksten J; Kogner P; Samuelsson U
Article: PIGMENT CELL AND MELANOMA RESEARCH. 2004;17(4):346-351
Pterin-dependent tyrosine hydroxylase mRNA is not expressed in human melanocytes or melanoma cells
Kågedal B; Kullman A; Lenner L; Träger C; Kogner P; Farnebäck M
Article: BRITISH JOURNAL OF CANCER. 2004;90(2):515-521
SLIT2 promoter methylation analysis in neuroblastoma, Wilms tumour and renal cell carcinoma
Astuti D; da Silva NF; Dallol A; Gentle D; Martinsson T; Kogner P; Grundy R; Kishida T; Yao M; Latif F; Maher ER
Article: CANCER RESEARCH. 2003;63(22):8006-8013
Retinoids act as multistep modulators of the major histocompatibility class I presentation pathway and sensitize neuroblastomas to cytotoxic lymphocytes
Vertuani S; De Geer A; Levitsky V; Kogner P; Kiessling R; Levitskaya J
Article: ONCOLOGY REPORTS. 2003;10(5):1587-1592
Evaluation of anti-tumour effects of oral fenretinide (4-HPR) in rats with human neuroblastoma xenografts
Ponthan F; Lindskog M; Karnehed N; Castro J; Kogner P
Article: JOURNAL OF CLINICAL ONCOLOGY. 2003;21(11):2077-2084
Quality assessment of genetic markers used for therapy stratification
Ambros IM; Benard J; Boavida M; Bown N; Caron H; Combaret V; Couturier J; Darnfors C; Delattre O; Freeman-Edward J; Gambini C; Gross N; Hattinger CM; Luegmayr A; Lunec J; Martinsson T; Mazzocco K; Navarro S; Noguera R; O'Neill S; Pötschger U; Rumpler S; Speleman F; Tonini GP; Valent A; Van Roy N; Amann G; De Bernardi B; Kogner P; Ladenstein R; Mickon J; Pearson ADJ; Ambros PF
Article: INTERNATIONAL JOURNAL OF CANCER. 2003;104(4):418-424
The synthetic retinoid Ro 13-6307 induces neuroblastoma differentiation in vitro and inhibits neuroblastoma tumour growth in vivo
Ponthan F; Johnsen JI; Klevenvall L; Castro J; Kogner P
Article: ONCOGENE. 2003;22(15):2343-2351
Screening for gene mutations in a 500 kb neuroblastoma tumor suppressor candidate region in chromosome 1p;: mutation and stage-specific expression in UBE4B/UFD2
Krona C; Ejeskär K; Abel F; Kogner P; Bjelke J; Björk E; Sjöberg RM; Martinsson T
Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2003;22(3):579-588
Apoptosis and tumor remission in liver tumor xenografts by 4-phenylbutyrate
Svechnikova I; Gray SG; Kundrotiene J; Ponthan F; Kogner P; Ekström TJ
Article: BRITISH JOURNAL OF CANCER. 2003;88(3):478-485
Noninvasive estimation of tumour viability in a xenograft model of human neuroblastoma with proton magnetic resonance spectroscopy (¹H MRS)
Lindskog M; Kogner P; Ponthan F; Schweinhardt P; Sandstedt B; Heiden T; Helms G; Spenger C
Article: CLINICAL CHEMISTRY. 2003;49(1):104-112
Quantitative analysis of tyrosine hydroxylase mRNA for sensitive detection of neuroblastorna cells in blood and bone marrow
Träger C; Kogner P; Lindskog M; Ponthan F; Kullman A; Kågedal B
Article: NEUROENDOCRINOLOGY. 2002;75(2):130-138
Elevated expression of galanin receptors in childhood neuroblastic tumors
Berger A; Tuechler C; Almer D; Kogner P; Ratschek M; Kerbl R; Lismaa TP; Jones N; Sperl W; Kofler B
Article: BRITISH JOURNAL OF CANCER. 2001;85(12):2004-2009
Bioavailability and dose-dependent anti-tumour effects of 9-cis retinoic acid on human neuroblastoma xenografts in rat
Ponthan F; Kogner P; Bjellerup P; Klevenvall L; Hassan M
Article: ONCOGENE. 2001;20(51):7573-7577
RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours
Astuti D; Agathanggelou A; Honorio S; Dallol A; Martinsson T; Kogner P; Cummins C; Neumann HPH; Voutilainen R; Dahia P; Eng C; Maher ER; Latif F
Article: ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY. 2001;92(4):420-423
Severe oral mucositis after therapeutic administration of [¹³¹I]MIBG in a child with neuroblastoma
Dahllöf G; Borgström P; Lundell G; Jacobsson H; Kogner P
Article: JOURNAL OF INTERNAL MEDICINE. 2000;248(4):299-308
Associations of leptin, insulin resistance and thyroid function with long-term weight loss in dieting obese men
Näslund E; Andersson I; Degerblad M; Kogner P; Kral JG; Rössner S; Hellström PM
Article: INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE. 2000;6(2):161-169
Expression of genes involved with cell cycle control, cell growth and chromatin modification are altered in hepatoblastomas
Gray SG; Hartmann W; Eriksson T; Ekström C; Holm S; Kytölä S; von Schweinitz D; Pietsch T; Larsson C; Kogner P; Sandstedt B; Ekström TJ
Article: BRITISH JOURNAL OF CANCER. 2000;83(2):171-176
Limited neuropeptide Y precursor processing in unfavourable metastatic neuroblastoma tumours
Bjellerup P; Theodorsson E; Jörnvall H; Kogner P
Article: BRITISH JOURNAL OF CANCER. 2000;82(9):1561-1567
Altered expression of members of the IGF-axis in hepatoblastomas
Gray SG; Eriksson T; Ekström C; Holm S; von Schweinitz D; Kogner P; Sandstedt B; Pietsch T; Ekström TJ
Article: CYTOGENETIC AND GENOME RESEARCH. 2000;89(1-2):62-66
Fine mapping of the human preprocortistatin gene (CORT) to neuroblastoma consensus deletion region 1p36.3→p36.2, but absence of mutations in primary tumors
Ejeskär K; Abel F; Sjöberg RM; Bäckström J; Kogner P; Martinsson T
Article: BRITISH JOURNAL OF CANCER. 1999;81(8):1402-1409
Gain of chromosome arm 17q is associated with unfavourable prognosis in neuroblastoma, but does not involve mutations in the somatostatin receptor 2 (SSTR2) gene at 17q24
Abel F; Ejeskär K; Kogner P; Martinsson T
Article: NUCLEAR MEDICINE AND BIOLOGY. 1999;26(8):931-936
Biodistribution of liposomal ¹³¹I-VIP in rat using gamma camera
Refai E; Jonsson C; Andersson M; Jacobsson H; Larsson S; Kogner P; Hassan M
Article: INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE. 1999;3(6):585-589
Variable expression and absence of mutations in p73 in primary neuroblastoma tumors argues against a role in neuroblastoma development
Ejeskär K; Sjöberg RM; Kogner P; Martinsson T
Article: BRITISH JOURNAL OF ANAESTHESIA. 1999;82(3):391-394
Neuropeptide Y response to tracheal intubation in anaesthetized children:: effects of clonidine vs midazolam as premedication
Bergendahl HTG; Eksborg S; Kogner P; Lönnqvist PA
Article: CANCER RESEARCH. 1999;59(5):1160-1163
A possible contributory role of BK virus infection in neuroblastoma development
Flægstad T; Andresen PA; Johnsen JI; Asomani SK; Jorgensen GE; Vignarajan S; Kjuul A; Kogner P; Traavik T
Article: LIFE SCIENCES. 1999;65(2):165-174
In vivo evaluation of the biodistribution of ¹¹C-labeled PD153035 in rats without and with neuroblastoma implants
Fredriksson A; Johnström P; Thorell JO; von Heijne G; Hassan M; Eksborg S; Kogner P; Borgström P; Ingvar M; Stone-Elander S
Article: NEUROSCIENCE LETTERS. 1998;253(1):17-20
Levels and molecular forms of chromogranins in human childhood neuroblastomas and ganglioneuromas
Eder U; Fischer-Colbrie R; Kogner P; Leitner B; Bjellerup P; Winkler H
Article: BRITISH JOURNAL OF CANCER. 1998;77(11):1787-1791
Loss of heterozygosity of 3p markers in neuroblastoma tumours implicate a tumour-suppressor locus distal to the FHIT gene
Ejeskär K; Aburatani H; Abrahamsson J; Kogner P; Martinsson T
Article: CANCER RESEARCH. 1998;58(3):448-452
A lack of neuroblastoma in Down syndrome:: A study from 11 European countries
Satgé D; Sasco AJ; Carlsen NLT; Stiller CA; Rubie H; Hero B; de Bernardi B; de Kraker J; Coze C; Kogner P; Langmark F; Hakvoort-Cammel FGAJ; Beck D; von der Weid N; Parkes S; Hartmann O; Lippens RJJ; Kamps WA; Sommelet D
Article: INTERNATIONAL JOURNAL OF CANCER. 1998;75(2):176-180
Promoter-specific methylation and expression alterations of igf2 and h19 are involved in human hepatoblastoma
Li XR; Kogner P; Sandstedt B; Haas OA; Ekström TJ
Article: ARCHIVES OF ORAL BIOLOGY. 1997;42(12):869-876
Effects of capsaicin in temporomandibular joint arthritis in rats
Carleson J; Kogner P; Bileviciute I; Theodorsson E; Appelgren A; Appelgren B; Kopp S; Yousef N; Lundeberg T
Article: CANCER GENETICS. 1997;95(2):183-189
Homozygous deletion of the neurofibromatosis-1 gene in the tumor of a patient with neuroblastoma
Martinsson T; Sjoberg RM; Hedborg F; Kogner P
Article: AMERICAN JOURNAL OF MEDICAL GENETICS, PART A. 1996;65(1):60-67
Monosomy 1p36.31-33->pter due to a paternal reciprocal translocation: Prognostic significance of FISH analysis
Blennow E; Bui TH; Wallin A; Kogner P
Article: BRITISH JOURNAL OF CANCER. 1996;74(5):773-779
Expression of mRNA for the neurotrophin receptor trkC in neuroblastomas with favourable tumour stage and good prognosis
Ryden M; Sehgal R; Dominici C; Schilling FH; Ibanez CF; Kogner P
Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 1996;8(6):1137-1142
Analysis of location and integrity of the human PITSLRE (p58(cdc2L1)) genes in neuroblastoma cell genomes: Evidence against involvement in tumorigenesis
Sjoberg RM; Hallstensson K; Nordling M; Kogner P; Gardellin P; Lubyova B; Onyango P; Weith A; Martinsson T
Article: CANCER RESEARCH. 1995;55(23):5681-5686
DELETION OF CHROMOSOME 1P LOCI AND MICROSATELLITE INSTABILITY IN NEUROBLASTOMAS ANALYZED WITH SHORT-TANDEM REPEAT POLYMORPHISMS
MARTINSSON T; SJOBERG RM; HEDBORG F; KOGNER P
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 1995;92(1):195-199
FALL-39, A PUTATIVE HUMAN PEPTIDE ANTIBIOTIC, IS CYSTEINE-FREE AND EXPRESSED IN BONE-MARROW AND TESTIS
AGERBERTH B; GUNNE H; ODEBERG J; KOGNER P; BOMAN HG; GUDMUNDSSON GH
Article: EUROPEAN JOURNAL OF CANCER. 1995;31A(4):557-560
PANCREASTATIN IMMUNOREACTIVITY IN FAVORABLE CHILDHOOD NEUROBLASTOMA AND GANGLIONEUROMA
KOGNER P; BJELLERUP P; SVENSSON T; THEODORSSON E
Article: EUROPEAN JOURNAL OF CANCER. 1995;31A(4):481-485
SOMATOSTATIN AND VASOACTIVE-INTESTINAL-PEPTIDE (VIP) IN NEUROBLASTOMA AND GANGLIONEUROMA - CHROMATOGRAPHIC CHARACTERIZATION AND RELEASE DURING SURGERY
BJELLERUP P; THEODORSSON E; KOGNER P
Show more

All other publications

Review: PEDIATRICS. 2024;154(2):e2024066081
Bone Mineral Density in Survivors of Childhood Cancer: A Meta-Analysis.
Velentza L; Filis P; Wilhelmsson M; Kogner P; Herold N; Sävendahl L
Review: JOURNAL OF CLINICAL ONCOLOGY. 2024;42(18):2219-2232
Use of Sodium Thiosulfate as an Otoprotectant in Patients With Cancer Treated With Platinum Compounds: A Review of the Literature
Meijer AJM; Diepstraten FA; Ansari M; Bouffet E; Bleyer A; Fresneau B; Geller JI; Huitema ADR; Kogner P; Maibach R; O'Neill AF; Papadakis V; Rajput KM; Veal GJ; Sullivan M; van den Heuvel-eibrink MM; Brock PR
Editorial comment: PEDIATRIC BLOOD AND CANCER. 2023;70(5):e30248
Sodium thiosulfate as cisplatin otoprotectant in children: The challenge of when to use it
Brock P; Meijer A; Kogner P; Ansari M; Capra M; Geller J; van den Heuvel-Eibrink M; Knight K; Kruger M; Lindemulder S; Maibach R; O'Neill A; Papadakis V; Rajput K; Bleyer A; Bouffet E; Sullivan M
Published conference paper: ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY. 2019;1161:89-100
Targeting the COX/mPGES-1/PGE2 Pathway in Neuroblastoma
Larsson K; Kock A; Kogner P; Jakobsson P-J
Review: EXPERT OPINION ON DRUG DISCOVERY. 2017;12(8):801-811
Accelerating drug development for neuroblastoma - New Drug Development Strategy: an Innovative Therapies for Children with Cancer, European Network for Cancer Research in Children and Adolescents and International Society of Paediatric Oncology Europe Neuroblastoma project
Moreno L; Caron H; Geoerger B; Eggert A; Schleiermacher G; Brock P; Valteau-Couanet D; Chesler L; Schulte JH; De Preter K; Molenaar J; Schramm A; Eilers M; Van Maerken T; Johnsen JI; Garrett M; George SL; Tweddle DA; Kogner P; Berthold F; Koster J; Barone G; Tucker ER; Marshall L; Herold R; Sterba J; Norga K; Vassal G; Pearson ADJ
Letter: JOURNAL OF CLINICAL ONCOLOGY. 2017;35(17):1965-1966
Improved Local Control by Extensive Surgery in High-Risk Neuroblastoma May Be Dependent on Adjuvant Radiotherapy
Stenman J; Herold N; Svensson P-J; Kogner P
Letter: THE LANCET ONCOLOGY. 2016;17(8):e319-e320
Venetoclax in cancer therapy and potential effects on bone
Zaman F; Kogner P; Savendahl L
Review: EXPERIMENTAL CELL RESEARCH. 2010;316(8):1365-1373
Omega-3 fatty acids in cancer, the protectors of good and the killers of evil?
Gleissman H; Johnsen JI; Kogner P
Review: APOPTOSIS : AN INTERNATIONAL JOURNAL ON PROGRAMMED CELL DEATH. 2009;14(4):424-438
Embryonal neural tumours and cell death
Johnsen JI; Kogner P; Albihn A; Henriksson MA
Review: CANCER LETTERS. 2005;228(1-2):195-201
NSAIDs in neuroblastoma therapy
Johnsen JI; Lindskog M; Ponthan F; Pettersen I; Elfman L; Orrego A; Sveinbjörnsson B; Kogner P
Review: CANCER LETTERS. 2005;228(1-2):247-255
Proton magnetic resonance spectroscopy in neuroblastoma:: Current status, prospects and limitations
Lindskog M; Spenger C; Klason T; Jarvet J; Gräslund A; Johnsen JI; Ponthan F; Douglas L; Nordell B; Kogner P
Published conference paper: NEUROPEPTIDES. 2005;39(3):353-359
Galanin and galanin receptors in human cancers
Berger A; Santic R; Hauser-Kronberger C; Schilling FH; Kogner P; Ratschek M; Gamper A; Jones N; Sperl W; Kofler B
Published conference paper: SPECTROSCOPY. 2004;18(2):123-132
Monitoring intracellular metabolites in neuroblastoma with 1H NMR spectroscopy: effects of growth factor withdrawal and modulation of lipid metabolism
Lindskog M; Jarvet J; Graslund A; Kogner P
Published conference paper: PEDIATRIC BLOOD AND CANCER. 2002;38(1):33-40
Fine needle aspiration cytology in the diagnosis and management of children and adolescents with Ewing sarcoma and peripheral primitive neuroectodermal tumor
Fröstad B; Tani E; Brosjö O; Skoog L; Kogner P
Published conference paper: PEDIATRIC BLOOD AND CANCER. 2001;36(1):61-66
Fine mapping of a tumour suppressor candidate gene region in 1p36.2-3, commonly deleted in neuroblastomas and germ cell tumours
Ejeskär K; Sjöberg RM; Abel F; Kogner P; Ambros PF; Martinsson T
Published conference paper: PEDIATRIC BLOOD AND CANCER. 2001;36(1):56-60
Absence of somatostatin receptor expression in vivo is correlated to di- or tetraploid 1p36-deleted neuroblastomas
Schilling FH; Ambros PF; Bihl H; Martinsson T; Ambros IM; Borgström P; Jacobsson H; Falkmer UG; Treuner J; Kogner P
Published conference paper: PEDIATRIC BLOOD AND CANCER. 2001;36(1):127-131
The vitamin A analogues:: 13-cis retinoic acid, 9-cis retinoic acid, and Ro 13-6307 inhibit neuroblastoma tumour growth in vivo
Ponthan F; Borgström P; Hassan M; Wassberg E; Redfern CPF; Kogner P
Published conference paper: PEDIATRIC BLOOD AND CANCER. 2000;35(6):688-691
Combined ¹¹¹In-pentetreotide scintigraphy and ¹²³I-mIBG scintigraphy in neuroblastoma provides prognostic information
Schilling FH; Bihl H; Jacobsson H; Ambros PF; Martinsson T; Borgström P; Schwarz K; Ambros IM; Treuner J; Kogner P
Published conference paper: PEDIATRIC BLOOD AND CANCER. 2000;35(6):593-596
Human polyomavirus BK (BKV) and neuroblastoma:: Mechanisms of oncogenic action and possible strategy for novel treatment
Jorgensen GEK; Johnsen JI; Ponthan F; Kogner P; Flægstad T; Traavik T
Published conference paper: PEDIATRIC RESEARCH. 1999;46(3):328-332
The somatostatin analogue octreotide inhibits neuroblastoma growth in vivo
Borgström P; Hassan M; Wassberg E; Refai E; Jonsson C; Larsson SA; Jacobsson H; Kogner P
Published conference paper: CANCER. 1999;87(2):60-68
The use of fine-needle aspiration cytology in the molecular characterization of neuroblastoma in children
Fröstad B; Martinsson T; Tani E; Falkmer U; Darnfors C; Skoog L; Kogner P
Published conference paper: PEDIATRIC BLOOD AND CANCER. 1998;31(5):421-425
Screening for neuroblastoma: Ethical and psychological aspects
Philip T; Ladenstein R; Kogner P; Perrier L; Bergeron C
Published conference paper: PEDIATRIC BLOOD AND CANCER. 1998;31(5):408-418
What can we expect from neuroblastoma screening? Clinicians point of view
Ladenstein R; Matthay K; Berthold F; Kogner P; Pearson ADJ; Frappaz D; DeBernardi B; Yamamoto K; Hartmann O
Published conference paper: EUROPEAN JOURNAL OF CANCER. 1998;34(4):529-536
The clinical use of fine needle aspiration cytology for diagnosis and management of children with neuroblastic tumours
Fröstad B; Tani E; Kogner P; Maeda S; Björk O; Skoog L
Published conference paper: EUROPEAN JOURNAL OF CANCER. 1997;33(12):2058-2063
Coexpression of mRNA for the full-length neurotrophin receptor trk-C and trk-A in favourable neuroblastoma
Svensson T; Rydén M; Schilling FH; Dominici C; Sehgal R; Ibáñez CF; Kogner P
Published conference paper: EUROPEAN JOURNAL OF CANCER. 1997;33(12):2113-2116
The International Neuroblastoma Risk Groups (INRG): a preliminary report
Castleberry RP; Pritchard J; Ambros P; Berthold F; Brodeur GM; Castel V; Cohn SL; De Bernardi B; Dicks-Mireaux C; Frappaz D; Haase GM; Haber M; Jones DR; Joshi VV; Kaneko M; Kemshead JT; Kogner P; Lee REJ; Matthay KK; Michon JM; Monclair R; Roald BR; Seeger RC; Shaw PJ; Shimada H; Shuster JJ
Published conference paper: EUROPEAN JOURNAL OF CANCER. 1997;33(12):2084-2089
Somatostatin in neuroblastoma and ganglioneuroma
Kogner P; Borgström P; Bjellerup P; Schilling FH; Refai E; Jonsson C; Dominici C; Wassberg E; Bihl H; Jacobsson H; Theodorsson E; Hassan M
Published conference paper: EUROPEAN JOURNAL OF CANCER. 1997;33(12):2037-2042
Analysis of candidate gene co-amplification with MYCN in neuroblastoma
George RE; Kenyon R; McGuckin AG; Kohl N; Kogner P; Christiansen H; Pearson ADJ; Lunec J
Published conference paper: EUROPEAN JOURNAL OF CANCER. 1997;33(12):1997-2001
Delimitation of a critical tumour suppressor region at distal 1p in neuroblastoma tumours
Martinsson T; Sjöberg RM; Hallstensson K; Nordling M; Hedborg F; Kogner P
Published conference paper: VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY. 1996;54(1-4):127-131
PR-39, a proline-rich peptide antibiotic from pig, and FALL-39, a tentative human counterpart
Agerberth B; Gunne H; Odeberg J; Kogner P; Boman HG; Gudmundsson GH
Other: ACTA ANAESTHESIOLOGICA SCANDINAVICA. 1995;39(5):705-708
ADENOSINE FOR PEROPERATIVE BLOOD-PRESSURE CONTROL IN AN INFANT WITH NEUROBLASTOMA
SELLDEN H; KOGNER P; SOLLEVI A
Review: PROGRESS IN BRAIN RESEARCH. 1995;104:325-338
Neuropeptides in neuroblastomas and ganglioneuromas
Kogner P
Show more

Articles

All other publications

News from KI

Events from KI